Literature DB >> 11222727

TRADD domain of Epstein-Barr virus transforming protein LMP1 is essential for inducing immortalization and suppressing senescence of primary rodent fibroblasts.

B Xin1, Z He, X Yang, C P Chan, M H Ng, L Cao.   

Abstract

Mutation analysis of latent membrane protein 1 (LMP1) in Epstein-Barr virus (EBV)-induced B-cell immortalization revealed two transformation effector sites, TES1 and TES2. TES2 mediates the interaction with tumor necrosis factor receptor-associated death domain protein (TRADD) and plays a key role in transactivating NF-kappa B and AP-1. Recombinant EBV containing LMP1 with TES2 deleted induces a limited proliferation of B cells. The present study shows that a mutant with an LMP1 site-specific mutation at TES2, LMP1(TRADD), initially stimulates cell growth and significantly extends the life span of MEF. However, it is not sufficient for the immortalization of MEF, and MEF-LMP1(TRADD) cells eventually enter growth arrest. Further analysis reveals that although LMP1(TRADD) promotes cell growth, it does not prevent the eventual onset of senescence and the expression of tumor suppressor p16(Ink4a).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222727      PMCID: PMC115928          DOI: 10.1128/JVI.75.6.3010-3015.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.

Authors:  S Leppä; D Bohmann
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

3.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

4.  An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; H Li; E Johannsen; D Davidson; R Longnecker; E Kieff
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.

Authors:  A G Eliopoulos; N J Gallagher; S M Blake; C W Dawson; L S Young
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

6.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

Authors:  E Cabannes; G Khan; F Aillet; R F Jarrett; R T Hay
Journal:  Oncogene       Date:  1999-05-20       Impact factor: 9.867

Review 7.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 8.  Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

Authors:  E D Cahir McFarland; K M Izumi; G Mosialos
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

9.  Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

Authors:  D Krappmann; F Emmerich; U Kordes; E Scharschmidt; B Dörken; C Scheidereit
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

10.  Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.

Authors:  G H Stein; L F Drullinger; A Soulard; V Dulić
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

View more
  6 in total

1.  TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

Authors:  Aristides G Eliopoulos; Elyse R Waites; Sarah M S Blake; Clare Davies; Paul Murray; Lawrence S Young
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Proteome analysis of the transformation potential of the Epstein-Barr virus-encoded latent membrane protein 1 in nasopharyngeal epithelial cells NP69.

Authors:  Qiong Zhang; Zhiwei Zhang; Chengkun Wang; Zhiqiang Xiao; Yanhui Yu; Fang Yang; Zhuchu Chen; Zhimin He
Journal:  Mol Cell Biochem       Date:  2008-04-19       Impact factor: 3.396

3.  Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.

Authors:  Jia Wang; Xiang Zheng; Zailong Qin; Lingyu Wei; Yuanjun Lu; Qiu Peng; Yingxue Gao; Xuemei Zhang; Xiaoyue Zhang; Zhengshuo Li; Yuxin Fu; Peishan Liu; Can Liu; Qun Yan; Wei Xiong; Guiyuan Li; Jianhong Lu; Jian Ma
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

4.  BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.

Authors:  Xubing Long; Yuqing Li; Mengtian Yang; Lu Huang; Weijie Gong; Ersheng Kuang
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 5.  New Look of EBV LMP1 Signaling Landscape.

Authors:  Ling Wang; Shunbin Ning
Journal:  Cancers (Basel)       Date:  2021-10-29       Impact factor: 6.575

6.  Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.

Authors:  Naoko Ohtani; Paul Brennan; Stefan Gaubatz; Elaine Sanij; Paul Hertzog; Ernst Wolvetang; Jacques Ghysdael; Martin Rowe; Eiji Hara
Journal:  J Cell Biol       Date:  2003-07-14       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.